CRP and schizophrenia: The importance of understanding the different sources of variation in APP levels throughout life is illustrated by recent studies supporting a causal role of CRP levels in schizophrenia, cancer, and cardiovascular disease (Said et al., 2022) along with evidence associating immune system variation during early life with autoimmune and inflammatory conditions later in life (Lee et al., 2022).